Intravesical bacillus Calmette-Guérin (BCG) in superficial bladder tumors. An overview
Debruyne, F.M.; Witjes, J.A.; vd Meijden, A.P.
Archivos Espanoles de Urologia 43(Suppl): 133-138
1990
ISSN/ISBN: 0004-0614 PMID: 2096774 Document Number: 356314
Document emailed within 1 workday
Related Documents
Shapiro, A.; Ratliff, T.L.; Oakley, D.M.; Catalona, W.J. 1983: Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity Cancer Research 43(4): 1611-1615De Boer, E.C.; De Jong, W.H.; Steerenberg, P.A.; Van der Meijden, A.P.; Aarden, L.A.; Debruyne, F.M.; Ruitenberg, E.J. 1991: Leukocytes and cytokines in the urine of superficial bladder cancer patients after intravesical immunotherapy with bacillus Calmette-Guerin In Vivo 5(6): 671-677
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Moyano Calvo, J.L.; Sanz Sacristán, J.; Teba del Pino, F.; Fernández Arjona, M.; Peinado Ibarra, F.; Mélon Rey, F.; Herrero Torres, L.; Rabadán Ruiz, M.; Arellano Gañán, R.; Albacete Almodóvar, P. 1995: Calmette-Guerin bacillus in the prophylaxis of superficial bladder tumors. our experience and our doubts Archivos Espanoles de Urologia 48(8): 791-795
Iturralde Codina, A.; Beyríe Tamayo, W.; Gozá León, F.; Muñoz, Y.I. 2004: Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes Archivos Espanoles de Urologia 57(6): 606-618
Flam, T.A.; Chopin, D.K.; Leleu, C.; Abbou, C.C.; Steg, A.; Deslignères, S.; Boccon-Gibod, L. 1990: Immunohistochemical markers defined by monoclonal antibodies and response to bacillus Calmette-Guérin endovesical immunotherapy for superficial bladder tumors European Urology 17(4): 338-342
Nishino, Y.; Yasuda, M.; Yokoi, S.; Ehara, H.; Yamamoto, N.; Takahashi, Y.; Ishihara, S.; Deguchi, T.; Kawada, Y.; Takeda, A.; Sakai, S.; Takeuchi, T.; Taniguchi, M.; Minoshima, K.; Hamamoto, Y.; Kanimoto, Y.; Nakano, M.; Fujihiro, S.; Nezasa, S.; Matsuda, T.; Nagatani, Y.; Maeda, S.; Tamaki, M.; Saito, A.; Komeda, H. 1999: Bacillus Calmette-Guerin intravesical instillation treatment for carcinoma in situ of the bladder. Gifu BCG Instillation Therapy Research Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(12): 1869-1873
Lamm, D.L.; Harris, S.C.; Gittes, R.F. 1977: Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors Investigative Urology 14(5): 369-372
Lee, P.P. 2015: Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations Annals of the Academy of Medicine Singapore 44(8): 297-301
Borré, S.; Brustia, D.; Rosa, F.; Brondolo, R.; Rizzo, G.; Garavelli, P.L. 2002: Calmette-Guerin bacillus disseminated infection after intravesical instillation Recenti Progressi in Medicina 93(4): 247-248
De Saint Martin, L.; Boiron, C.; Poveda, J.D.; Herreman, G. 1993: Generalized BCG infection after intravesical instillations of Calmette-Guerin bacillus Presse Medicale 22(29): 1352-1356
Milas, L.; Maillefert, J.F.; Michel, F.; Piroth, C.; Wautot, A.; Tavernier, C. 1999: Refractory arthropathy after intravesical bacillus Calmette-Guérin therapy. Usefulness of isoniazide Revue du Rhumatisme 66(2): 106-108
Mitropoulos, D.; Deliconstantinos, G.; Zervas, A.; Giannopoulos, A.; Kyriakou, G.; Dimopoulos, C. 2000: Oxidative stress of red blood cells during Bacillus Calmette-Guerin intravesical instillations In Vivo 14(6): 721-724
Kuramoto, T.; Nishikawa, T.; Nanpou, Y. 2018: A Case Report of Granulomatous Renal Masses Following Intravesical Instillation of Bacillus Calmette-Guérin Therapy Hinyokika Kiyo. Acta Urologica Japonica 64(5): 225-230
Muranaka, T.; Kunishima, Y.; Shigyo, M.; Kato, R.; Masumori, N.; Ito, N.; Tsukamoto, T.; Takagi, Y.; Seki, M.; Toida, I. 2007: Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report Hinyokika Kiyo. Acta Urologica Japonica 53(8): 581-584
Vázquez-Lavista, L.G.; Flores-Balcázar, C.H.é; Llorente, L. 2007: The bacillus Calmette-Guérin as immunomodulator in bladder cancer Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 59(2): 146-152
Skaugen, P. 1997: Bacillus Calmette-Guerin therapy for bladder carcinoma in situ: use in a clinical setting Urologic Nursing 17(2): 69-71
Jurincic-Winkler, C.; Metz, K.A.; Beuth, J.; Sippel, J.; Klippel, K.F. 1995: Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder Anticancer Research 15(6b): 2771-2776
Luo, Y.; Chen, X.; Downs, T.M.; DeWolf, W.C.; O'Donnell, M.A. 1999: IFN-alpha 2B enhances Th1 cytokine responses in bladder cancer patients receiving Mycobacterium bovis bacillus Calmette-Guérin immunotherapy Journal of Immunology 162(4): 2399-2405
Houchens, D.P.; Goldberg, A.I.; Gaston, M.R.; Kende, M.; Goldin, A. 1973: Studies of the effects of Bacillus Calmette-Guérin on Moloney sarcoma virus-induced tumors in normal and immunosuppressed mice Cancer Research 33(4): 685-690